|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2011-7-7
|
|
pubmed:abstractText |
To evaluate the current clinical evidence of safety and efficacy of intraoperative topical application of 0.02% mitomycin C (MMC) used for up to 2 minutes after surface ablation for correction of myopia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1081-597X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2011, SLACK Incorporated.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
530-41
|
|
pubmed:meshHeading |
pubmed-meshheading:21243972-Alkylating Agents,
pubmed-meshheading:21243972-Cornea,
pubmed-meshheading:21243972-Corneal Topography,
pubmed-meshheading:21243972-Dose-Response Relationship, Drug,
pubmed-meshheading:21243972-Humans,
pubmed-meshheading:21243972-Keratectomy, Subepithelial, Laser-Assisted,
pubmed-meshheading:21243972-Mitomycin,
pubmed-meshheading:21243972-Myopia,
pubmed-meshheading:21243972-Ophthalmic Solutions,
pubmed-meshheading:21243972-Treatment Outcome,
pubmed-meshheading:21243972-Visual Acuity
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C.
|
|
pubmed:affiliation |
Wenzhou Medical College, Zhejiang, China.
|
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|
